Sanofi’s MenQuadfi Meningococcal vaccine receives FDA approval
by Press Release from Outbreak News Today on (#52SK4)
The U.S. Food and Drug Administration (FDA) has approved a Biologics License Application for MenQuadfiTM Meningococcal (Groups A, C, Y, W) Conjugate Vaccine for the prevention of invasive meningococcal disease in persons 2 years of age and older. "Meningococcal meningitis remains a major global health challenge because it can strike quickly and with devastating effect, taking ["]
The post Sanofi's MenQuadfi Meningococcal vaccine receives FDA approval appeared first on Outbreak News Today.